Company news
GENinCode PLC news in 2025
GENinCode PLC's news releases, calls and decks from 2025, newest first.
Collaboration with Sohin Genetics
December 17, 2025
Collaboration with Thermo Fisher
December 4, 2025
Approval of CARDIO inCode-score in New York state
December 3, 2025
New Study From GENinCode Shows Polygenic Risk Scores Improve the Accuracy of Cardiovascular Disease Risk Prediction
November 12, 2025
Publication of Landmark Study in JACC: Advances
October 28, 2025
Half-year Report
September 30, 2025
NHS (UCLH) Risk of Ovarian Cancer (ROCA) launch
September 25, 2025
Stmnt re Share Price Movement
September 17, 2025
Notice of Results
September 5, 2025
Trading update
August 26, 2025
De Novo Update – FDA Supervisory Review
July 7, 2025
Result of AGM
June 30, 2025
Final Results
June 4, 2025
De Novo Submission Update
April 30, 2025
Grant of Share Options & PDMR Dealings
March 26, 2025
Result of General Meeting, Issue of Equity and TVR
March 3, 2025
CARDIO inCode Lab Fee Update & Catalonia Launch
January 23, 2025